Suraaj Party chief has been on hunger strike since January 2, protesting against irregularities in the 70th Bihar Public ...

Capsida to receive a $40 million license payment and is eligible for additional milestones and royalties  THOUSAND OAKS, ...

The primary safety endpoint was carried out through the percentage of patients with shift from normal (at baseline) to ...

Oculis’ peptidomimetic small molecule has been shown to help protect the eyes of patients with inflammation of the optic ...

Oncolytics Biotech Inc. (NASDAQ:ONCY – Get Free Report) traded up 3.2% on Friday . The company traded as high as $0.96 and last traded at $0.96. 263,496 shares were traded during trading, an increase ...

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

Researchers are making strides in improving gene therapies for genetic diseases, particularly chronic kidney disease, using adeno-associated virus, or AAV, vectors. While AAV-based treatments have ...

This study is the first to inject repeated doses of stem cells intravenously into patients who have heart failure due to a ...

Akamis Bio, a clinical-stage oncology company, has raised $60 million in Series A funding that will drive continued development of NG-350A, a new gene therapy based on its proprietary tumor ...

This dosage is so high it must be administered intravenously, not through dietary sources or supplements. The results were remarkable, according to Dr. Benga. "By getting a significant higher ...